| 溶栓技术在ST段抬高型心肌梗死救治中的地位 |
| |
| 引用本文： | 沈珠军. 溶栓技术在ST段抬高型心肌梗死救治中的地位[J]. 协和医学杂志, 2020, 11(2): 127-129. DOI: 10.3969/j.issn.1674-9081.20190265 |
| |
| 作者姓名： | 沈珠军 |
| |
| 作者单位： | 中国医学科学院 北京协和医学院 北京协和医院心内科, 北京 100730 |
| |
| 摘 要： | 急性ST段抬高型心肌梗死的再灌注治疗中,溶栓治疗作为解决这一血栓性疾病的治疗方式,仍应具有相当重要的地位.近些年溶栓治疗用于心肌梗死治疗的相关临床研究已分别证实:(1)在发病时间较早且介入开始时间可能延误较长(＞2 h)的情况下考虑首选;(2)在拟采取介入治疗但因有一些延误时(1 h)考虑使用低剂量溶栓药物辅助溶栓后再...
|
| 关 键 词： | ST段抬高型心肌梗死 溶栓治疗 介入治疗 |
| 收稿时间： | 2019-12-02 |
The Status of Thrombolytic Therapy in Treatment of ST-segment Elevation Myocardial Infarction |
| |
| Affiliation: | Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China |
| |
| Abstract: | Thrombolytic revascularization therapy still remains an important method in the treatment of ST-segment elevation myocardial infarction (STEMI). Recent clinical studies confirmed the status of thrombolytic therapy in 3 clinical situations:estimated long delay(>2 hours) in primary percutaneous coronary intervention (PCI), pharmco-invasive thrombolytic therapy with estimated PCI delay(1 hour), a large thrombus treated with intra-coronary use of low dose thrombolytic therapy during primary PCI. Above 3 conditions should be fully considered during clinical application. |
| |
| Keywords: | |
| 本文献已被 CNKI 等数据库收录！ |
| 点击此处可从《协和医学杂志》浏览原始摘要信息 |
|
点击此处可从《协和医学杂志》下载全文 |
|
